Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.
作者信息
Sahu Kamal Kant, Jindal Vishal, Siddiqui Ahmad Daniyal
机构信息
Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA.
Department of Hematology and Oncology, William Beaumont Hospital, Oakland University, Royal Oak, MI.
出版信息
JCO Oncol Pract. 2020 May;16(5):223-225. doi: 10.1200/OP.20.00167. Epub 2020 Apr 17.
Abstract
摘要
相似文献
1
Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.
JCO Oncol Pract. 2020 May;16(5):223-225. doi: 10.1200/OP.20.00167. Epub 2020 Apr 17.
2
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2020-000759.
3
Managing patients with cancer in the COVID-19 era.
Eur J Cancer. 2020 Jun;132:5-7. doi: 10.1016/j.ejca.2020.03.028. Epub 2020 Apr 11.
4
Risk of COVID-19 in Patients With Cancer.
JAMA Oncol. 2020 Sep 1;6(9):1471-1472. doi: 10.1001/jamaoncol.2020.2586.
5
Risk of COVID-19 in Patients With Cancer.
JAMA Oncol. 2020 Sep 1;6(9):1471. doi: 10.1001/jamaoncol.2020.2583.
6
Risk of COVID-19 in Patients With Cancer.
JAMA Oncol. 2020 Sep 1;6(9):1469-1470. doi: 10.1001/jamaoncol.2020.2577.
7
Risk of COVID-19 in Patients With Cancer.
JAMA Oncol. 2020 Sep 1;6(9):1470-1471. doi: 10.1001/jamaoncol.2020.2580.
8
Risk of COVID-19 for patients with cancer.
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
9
Risk of COVID-19 for patients with cancer.
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
10
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.
Eur Urol. 2020 Jul;78(1):e12-e13. doi: 10.1016/j.eururo.2020.04.015. Epub 2020 Apr 13.
引用本文的文献
1
Evaluation of clinical outcomes, laboratory and imaging data of patients with solid tumor infected with COVID-19 infection.
Int J Biochem Mol Biol. 2022 Dec 15;13(6):77-86. eCollection 2022.
2
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.
Cancers (Basel). 2022 May 17;14(10):2460. doi: 10.3390/cancers14102460.
3
Hematopoietic Stem Cell Transplantation During the Era of COVID-19 in Queen Rania Children's Hospital.
Mater Sociomed. 2021 Jun;33(2):131-137. doi: 10.5455/msm.2021.33.131-137.
4
Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic.
Adv Exp Med Biol. 2021;1318:759-771. doi: 10.1007/978-3-030-63761-3_42.
5
Challenges of Cellular Therapy During the COVID-19 Pandemic.
Adv Exp Med Biol. 2021;1318:657-672. doi: 10.1007/978-3-030-63761-3_36.
6
COVID-19 in Patients with Cancer.
Adv Exp Med Biol. 2021;1318:315-331. doi: 10.1007/978-3-030-63761-3_18.
7
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
Clin Exp Metastasis. 2021 Jun;38(3):257-261. doi: 10.1007/s10585-021-10083-1. Epub 2021 Mar 23.
8
Taking a step down on the reconstruction ladder for head and neck reconstruction during the COVID-19 pandemic.
BMC Surg. 2021 Mar 8;21(1):120. doi: 10.1186/s12893-021-01134-1.
9
Current Perspectives of convalescent plasma therapy in COVID-19.
Acta Biomed. 2020 Nov 10;91(4):e2020175. doi: 10.23750/abm.v91i4.10681.
10
The characteristics of cancerous patients infected with COVID-19 in hospital setting.
Acta Biomed. 2020 Nov 10;91(4):e2020145. doi: 10.23750/abm.v91i4.10175.
本文引用的文献
1
Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV).
Ann Transl Med. 2020 Mar;8(6):393. doi: 10.21037/atm.2020.02.92.
2
Risk of COVID-19 for patients with cancer.
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
3
Risk of COVID-19 for patients with cancer.
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
4
[The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease].
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):305-311. doi: 10.3760/cma.j.cn112152-20200303-00166.
5
Coronavirus disease-2019: An update on third coronavirus outbreak of 21st century.
QJM. 2020 May 1;113(5):384-386. doi: 10.1093/qjmed/hcaa081.
6
[Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer].
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):400-404. doi: 10.3760/cma.j.cn112138-20200219-00097.
7
[Several suggestion of operation for colorectal cancer under the outbreak of Corona Virus Disease 19 in China].
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 19;23(3):9-11. doi: 10.3760/cma.j.issn.1671-0274.2020.03.002.
8
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
9
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
Biosci Trends. 2020 Mar 16;14(1):64-68. doi: 10.5582/bst.2020.01030. Epub 2020 Feb 9.
10
A rare case of rituximab induced interstitial lung disease.
Lung India. 2016 Jul-Aug;33(4):472-3. doi: 10.4103/0970-2113.184960.
Zotero 插件